Adjusted rates of medications for opioid use disorder for pregnant women referred to treatment in Medicaid expansion and nonexpansion states for each referral source.
Opioid use disorder (OUD) among pregnant women in the United States has risen more than fourfold since 1999, making substance use a leading cause of maternal mortality. Medicaid finances the majority
Medications for opioid use disorder (MOUD) are the most effective interventions for this condition, yet many patients discontinue treatment. Though adjunct psychosocial treatments are recommended to i
IntroductionHuman-derived induced pluripotent stem cell (iPSC) models of brain promise to advance our understanding of neurotoxic consequences of drug use. However, how well these models recapitulate
Opioid use disorder (OUD) is underdiagnosed in health system settings, limiting research on OUD using electronic health records (EHRs). Medical encounter notes can enrich structured EHR data with docu
